|
Q4 2017
Filed on Feb 14, 2018
|
20,000
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
26,136
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
490,672
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
7,232
|
$0.37 - $0.49
$2.68K - $3.54K
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
65,000
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
50,000
|
$23.13 - $25.22
$1.16M - $1.26M
|
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
12,525
|
$48.05 - $51.66
$602K - $647K
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
2,500,000
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
86,501
|
$44.82 - $47.81
$3.88M - $4.14M
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
77,651
|
N/A
|
|
Level 3 Communications Inc
|
Q4 2017
Filed on Feb 14, 2018
|
199,167
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
298,627
|
N/A
|
|
National Westminster Bk PLC
|
Q4 2017
Filed on Feb 14, 2018
|
24,415
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
36,562
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
139,645
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
48,000
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
150,000
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
366,290
|
N/A
|
|
|
Royal Bk Scotland Group PLC
|
Q4 2017
Filed on Feb 14, 2018
|
421,276
|
N/A
|
|
Sciclone Pharmaceuticals Inc
|
Q4 2017
Filed on Feb 14, 2018
|
541,025
|
N/A
|
|
Southwest Bancorp Inc Okla
|
Q4 2017
Filed on Feb 14, 2018
|
144,154
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
390,500
|
$4.35 - $6.17
$1.7M - $2.41M
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
4,394
|
$40.35 - $48.42
$177K - $213K
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
2,400
|
$104.5 - $126.38
$251K - $303K
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
60,000
|
$17.29 - $25.05
$1.04M - $1.5M
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
31,000
|
$27.77 - $35.89
$861K - $1.11M
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
1,201,330
|
$3.72 - $4.16
$4.47M - $5M
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
320,526
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
7,285
|
$72.71 - $81.51
$530K - $594K
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
216,607
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
196,217
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
389,033
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
195,000
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
729,784
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
361,169
|
$21.39 - $25.8
$7.73M - $9.32M
|
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
33,053
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
129,026
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
41,122
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
181,415
|
N/A
|
|
Synchronoss Technologies Inc
|
Q4 2017
Filed on Feb 14, 2018
|
5,000,000
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
94,600
|
$23.6 - $32.67
$2.23M - $3.09M
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
109,300
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
2,000,000
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
30,000
|
$4.18 - $7.19
$125K - $216K
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
6,880
|
$28.3 - $30.21
$195K - $208K
|
|
Adamas Pharmaceuticals Inc
|
Q3 2017
Filed on Nov 14, 2017
|
20,000
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
13,767
|
$30.67 - $39.79
$422K - $548K
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
70,417
|
$20.95 - $21.84
$1.48M - $1.54M
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
2,127
|
$48.51 - $51.02
$103K - $109K
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
2,500,000
|
N/A
|
|